Stealth BioTherapeutics Company
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.
Investors
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Oxidative Phosphorylation
Investors Number:
8
Number Of Exists:
Post-IPO Equity
Technology:
Geroscience
Founded Date:
2007
Investor Type:
Company
Headquarters:
Cayman Islands
Total Funding:
$120M
Last Funding Type:
Post-IPO Equity
Employee Number:
101-250